Psychological Responses to BRCA1 Mutation Testing: Preliminary Findings

Health Psychology

Volumn 16, Issue 1, 1997, Pages 63-72

  Croyle, Robert T ^a   Smith, Ken R ^b   Botkin, Jeffrey R ^b   Baty, Bonnie ^b   Nash, Jean ^b  

^a UNIVERSITY OF UTAH   (United States)

^b NONE

Author keywords

BRCA1; Cancer; Genetic testing; Screening

Indexed keywords

ADOLESCENT; ADULT; AGED; ANXIETY; ARTICLE; BREAST TUMOR; CASE CONTROL STUDY; CONSANGUINITY; FEMALE; FOLLOW UP; GENETIC SCREENING; GENETICS; HETEROZYGOTE; HUMAN; MENTAL STRESS; MIDDLE AGED; MUTATION; NEOPLASM; PSYCHOLOGICAL ASPECT; REGRESSION ANALYSIS; TIME; TUMOR SUPPRESSOR GENE;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANXIETY; BREAST NEOPLASMS; CASE-CONTROL STUDIES; CONSANGUINITY; FEMALE; FOLLOW-UP STUDIES; GENES, BRCA1; GENETIC SCREENING; HETEROZYGOTE; HUMANS; MIDDLE AGED; MUTATION; NEOPLASMS; REGRESSION ANALYSIS; STRESS, PSYCHOLOGICAL; TIME FACTORS;

EID: 0030638330     PISSN: 02786133     EISSN: None     Source Type: Journal    
DOI: 10.1037/0278-6133.16.1.63     Document Type: Article

References (28)

1. Botkin, J. R., Croyle, R. T., Smith, K. R., Baty, B., Lerman, C., Goldgar, D., Ward, J., Flick, B., & Nash, J. (1996). A model protocol for evaluating the behavioral and psychological effects of BRCA1 testing. Journal of the National Cancer Institute, 88, 872-882.
2. Collins, F. S. (1996). BRCA1 - lots of mutations, lots of dilemmas. New England Journal of Medicine, 334, 186-188.
3. Croyle, R. T., Dutson, D. S., Tran, V. T., & Sun, Y. (1995). Need for certainty and interest in genetic testing. Women's Health: Research on Gender, Behavior, and Policy, 1, 329-339.
4. Croyle, R. T., & Lerman, C. (1995). Psychological impact of genetic testing. In R. T. Croyle (Ed.), Psychosocial effects of screening for disease prevention and detection (pp. 11-38). New York: Oxford University Press.
5. Dudok de Wit, A. C., Meijers-Heijboer, E. J., Tibben, A., Frets, P. G., Klijn, J. G. M., Devilee, P., & Niermeijer, M. F. (1994). Effect on a Dutch family of predictive DNA-testing for hereditary breast and ovarian cancer [Letter to the editor]. Lancet, 344, 197.
6. Easton, D. F., Ford, D., & Bishop, D. T. (1995). Breast and ovarian cancer incidence in BRCA1-mutation carriers. Breast Cancer Linkage Consortium. American Journal of Human Genetics, 56, 265-271.
7. Epping-Jordan, J. E., Compas, B. E., & Howell, D. C. (1994). Predictors of cancer progression in young adult men and women: Avoidance, intrusive thoughts, and psychological symptoms. Health Psychology, 13, 539-547.
8. Goldgar, D. E., Fields, P., Lewis, C. M., Tran, T. D., Cannon-Albright, L. A., Ward, J. H., Swensen, J., & Skolnick, M. H. (1994). A large kindred with 17q-linked breast and ovarian cancer: Genetic, phenotypic, and genealogical analysis. Journal of the National Cancer Institute, 86, 200-209.
9. Gottlieb, N. H., & Green, L. W. (1984). Life events, social network, life-style, and health: An analysis of the 1979 national survey on personal health practices and consequences. Health Education Quarterly, 11, 91-105.
10. Horowitz, M., Wilner, N., & Alvarez, W. (1979). The Impact of Event Scale: A measure of subjective stress. Psychosomatic Medicine, 41, 209-218.
11. Lazarus, R. S., & Folkman, S. (1984). Stress, appraisal, and coping. New York: Springer.
12. Lerman, C., Daly, M., Sands, C., Balshem, A., Lustbader, E., Heggan, T., Goldstein, L., James, J., & Engstrom, P. (1993). Mammography adherence and psychological distress among women at risk for breast cancer. Journal of the National Cancer Institute, 85, 1074-1080.
13. Lerman, C., Narod, S., Schulman, K., Hughes, C., Gomez-Caminero, A., Bonney, G., Gold, K., Trock, B., Main, D., Lynch, J., Fulmore, C., Snyder, C., Lemon, S. J., Conway, T., Tonin, P., Lenoir, G., & Lynch, H. (1996). BRCA1 testing in families with breast-ovarian cancer: A prospective study of patient decision-making and outcomes. Journal of the American Medical Association, 275, 1885-1892.
14. Lerman, C., Rimer, B. K., & Engstrom, P. F. (1991). Cancer risk notification: Psychosocial and ethical implications. Journal of Clinical Oncology, 9, 1275-1282.
15. Lerman, C., Seay, J., Balshem, A., & Audrain, J. (1995). Interest in genetic testing among first-degree relatives of breast cancer patients. American Journal of Medical Genetics, 57, 385-392.
16. Lynch, H. T., Watson, P., Conway, T. A., Lynch, J. F., Slominski-Caster, S. M., Narod, S. A., Feunteun, J., & Lenoir, G. (1993). DNA screening for breast/ovarian cancer susceptibility based on linked markers. Archives of Internal Medicine, 153, 1979-1987.
17. Miki, Y., Swensen, J., Shattuck-Eidens, D., Futreal, P. A., Harshman, K., Tavtigian, S., Liu, Q., Cochran, C., Bennett, L. M., Ding, W., Bell, R., Rosenthal, J., Hussey, C., Tranh, T., McClure, M., Frye, C., Hattier, T., Phelps, R., Haugen-Strano, A., Katcher, H., Yakumo, K., Gholami, Z., Shaffer, D., Stone, S., Bayer, S., Wray, C., Bogden, R., Dayanath, P., Ward, J., Tonin, P., Narod, S., Bristow, P. K., Norris, F. H., Helvering, L., Morrison, P., Rosteck, P., Lai, M., Barrett, J. C., Lewis, C., Neuhausen, S., Cannon-Albright, L., Goldgar, D., Wiseman, R., Kamb, A., & Skolnick, M. H. (1994). A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science, 266, 66-71.
18. Ortony, A., Clore, G. L., & Collins, A. (1988). The cognitive structure of emotions. New York: Cambridge University Press.
19. Rothstein, M. A. (1990). Legal and ethical issues in the laboratory assessment of genetic susceptibility to cancer. Birth Defects, 26, 179-190.
20. Spielberger, C. D. (1983). State-Trait Anxiety Inventory for Adults (Form Y). Palo Alto, CA: Mind Garden.
21. Spielberger, C. D., Gorsuch, R. L., & Lushene, R. E. (1970). Manual for the State-Trait Anxiety Inventory. Palo Alto, CA: Consulting Psychologists Press.
22. Struewing, J. P., Lerman, C., Kase, R. G., Giambarresi, T. R., & Tucker, M. A. (1995). Anticipated uptake and impact of genetic testing in hereditary breast and ovarian cancer families. Cancer Epidemiolology, Biomarkers and Prevention, 4, 169-173.
23. Szabo, C. I., & King, M. C. (1995). Inherited breast and ovarian cancer. Human Molecular Genetics, 4, 1811-1817.
24. Tibben, A., Duivenvoorden, H. J., Niermeijer, M. F., Vegter van der Vlis, M., Roos, R. A., & Verhage, F. (1994). Psychological effects of presymptomatic DNA testing for Huntington's disease in the Dutch program. Psychosomatic Medicine, 56, 526-532.
25. Tross, S., Herndon, J., II, Korzun, A., Kornblith, A. B., Cella, D. F., Holland, J. F., Raich, P., Johnson, A., Kiang, D. T., Perloff, M., Norton, L., Wood, W., & Holland, J. C. (1996). Psychological symptoms and disease-free and overall survival in women with Stage II breast cancer. Journal of the National Cancer Institute, 88, 661-667.
26. Watson, M., Murday, V., Lloyd, S., Ponder, B., Averill, D., & Eeles, R. (1995). Genetic testing in breast/ovarian cancer (BRCA1) families [Letter to the editor]. Lancet, 346, 583.
27. Wiggins, S., Whyte, P., Muggins, M., Adam, S., Theilmann, J., Bloch, M., Sheps, S. B., Schechter, M. T., & Hayden, M. R. (1992). The psychological consequences of predictive testing for Huntington's disease. Canadian Collaborative Study of Predictive Testing. New England Journal of Medicine, 327, 1401-1405.
28. Zilberg, N. J., Weiss, D. D., & Horowitz, M. J. (1982). Impact of Event Scale: A cross-sectional validation study and some empirical evidence supporting a conceptual model of stress response syndromes. Journal of Consulting and Clinical Psychology, 50, 407-414.